Bronchicine CAe



BRONCHICINE CAe is approved for the vaccination of healthy dogs 8 weeks of age or older as an aid in the control of canine infectious tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica.

BRONCHINE CAe is prepared from antigenic material extracted from the Bordetella bronchiseptica organism. An immunogenic strain of B. bronchiseptica is grown to a high yield, then subjected to a proprietary process which extracts the antigens from the B. bronchiseptica cells. The residual cell debris is then removed, resulting in a product which retains the desirable immunologic qualities of a whole cell bacterin, while reducing toxic and other undesirable side effects with whole cell bacterins.

Maker: Pfizer-Zoetis, USA

Price: Php 250 per shot

Leave a Reply

Your email address will not be published. Required fields are marked *